Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone

Am J Med. 2001 Nov;111(7):587. doi: 10.1016/s0002-9343(01)00927-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Diuretics / administration & dosage
  • Diuretics / adverse effects*
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Hyperkalemia / chemically induced*
  • Spironolactone / administration & dosage
  • Spironolactone / adverse effects*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Spironolactone